 2. Measureable disease by Serum M protein, or Urine M protein, or serum free light chain SFLC and an abnormal serum kappa lambda ratio for subjects without detectable serum or urine M-protein, or Serum quantitative immunoglobulin A qlgA for immunoglobulin Ig A subjects whose disease can only be reliable measured by qlgA. 